Pharmaceutical Bio Association Completes Formation of Drug Advertising Review Committee

On the 2nd, the Pharmaceutical Advertising Review Committee of the Korea Pharmaceutical and Bio-Pharma Manufacturers Association held a meeting at the Pharmaceutical Hall in Bangbae-dong, Seocho-gu, Seoul, and announced on the 3rd that Professor Jang Choon-gon of Sungkyunkwan University College of Pharmacy was appointed as the chairman. Kwon Sung-joon, director of Huons, and Professor Min Yang-gi of Hallym University Kangnam Sacred Heart Hospital were respectively elected as vice chairmen.


Jang Chun-gon, the new chairman of the Pharmaceutical Advertising Review Committee of the Korea Pharmaceutical and Bio-Pharma Manufacturers Association. <br>[Photo by Korea Pharmaceutical and Bio-Pharma Manufacturers Association]

Jang Chun-gon, the new chairman of the Pharmaceutical Advertising Review Committee of the Korea Pharmaceutical and Bio-Pharma Manufacturers Association.
[Photo by Korea Pharmaceutical and Bio-Pharma Manufacturers Association]

View original image

Before the meeting, Noh Yeon-hong, president of the Korea Pharmaceutical and Bio-Pharma Manufacturers Association, presented appointment letters to the committee members and said, "In the era of new media, the role of the Pharmaceutical Advertising Review Committee has become even more important amid rapidly changing environmental trends," adding, "I sincerely thank you for your efforts to contribute to the revitalization of the over-the-counter drug market and the improvement of public health through the provision of accurate information."


Chairman Jang said, "I feel a heavy responsibility in taking on the role of chairman at this important time when pharmaceutical advertising is changing," and added, "I will do my best to ensure that pharmaceutical advertising review can develop rationally in line with these changes."



This committee is composed of 16 members recommended from various sectors including the medical community, academia, legal profession, consumer groups, and the pharmaceutical industry. From this day until April 30, 2024, the members will carry out pharmaceutical advertising review duties based on the Pharmaceutical Affairs Act and the Pharmaceutical Advertising Review Regulations.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing